The exact reason 3-MCC remains benign for most patients is not fully understood, but the body often finds alternative metabolic pathways to manage the protein safely without causing toxic buildups [7] [2]
When Diarrhea May Signal a Need for Dose Adjustment Mild diarrhea lasting 12 weeks during dose transitions is expected and usually manageable with the strategies above
PlexusDx serves all 50 states without requiring insurance, with no membership fees, and HSA/FSA eligibility available
However, there have been only limited details of temporal changes of these post diagnosis, and with only a small overlap between the different study results [10]
PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to identify your unique predispositionsincluding variants in GLP1R (rs6923761), FTO (rs9939609), and MC4R (rs17782313)all of which affect how your body tolerates medication and responds to dietary changes
Tue-Fri 9 AM-7 PM